iBio, Inc. (NYSEMKT:IBIO – Get Free Report)’s share price dropped 6.8% during mid-day trading on Wednesday . The stock traded as low as $0.81 and last traded at $0.81. Approximately 281,569 shares were traded during trading, an increase of 149% from the average daily volume of 113,212 shares. The stock had previously closed at $0.87.
iBio Trading Up 10.5%
The firm’s fifty day moving average price is $0.90 and its 200 day moving average price is $2.54. The company has a debt-to-equity ratio of 0.04, a current ratio of 0.91 and a quick ratio of 0.91.
iBio Company Profile
iBio, Inc, a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases. The company’s technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein.
See Also
- Five stocks we like better than iBio
- A Deeper Look at Bid-Ask Spreads
- Chime’s Smart IPO: Half the Valuation, Double the Strength
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Why Quantum Computing Inc. Is the Quiet Winner in Quantum Stocks
- What is MarketRank™? How to Use it
- 3 Catalysts in 7 Days: Archer’s Growth Story Just Accelerated
Receive News & Ratings for iBio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iBio and related companies with MarketBeat.com's FREE daily email newsletter.
